Drug company set to lower cost of Daraprim after backlash

The CEO of Turing Pharmaceuticals says that the company will lower the cost of Daraprim after a backlashed caused by a sudden 5000% increase in the price of the drug used to treat cancer and AIDS patients. Don Dahler has the latest.

Sourced through Scoop.it from: www.cbsnews.com

The CEO Martin Shkreli of Turing Pharmaceuticals says that the company will lower the cost of Daraprim after a backlashed caused by a sudden 5000% increase in the price of the drug used to treat cancer and AIDS patients.  The 32-year-old founder took his Twitter account private Tuesday night after commenting prolifically on social media this week.  Driving on the internet under the influence of your own ego has it’s penalties, this is one of them.

See on Scoop.itInternet of Things – Company and Research Focus

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s